October 28, 2008 - Phenomix Initiates Phase 1a Clinical Trial of Hepatitis C Protease Inhibitor PHX1766 [READ MORE]
October 23, 2008 - Phenomix and Forest Laboratories to Collaborate on Development and Commercialization of Dutogliptin in Diabetes [READ MORE]